BIOTECanada Announces New Chair and Board of Directors Appointments

  BIOTECanada Announces New Chair and Board of Directors Appointments

Business Wire

MONTREAL -- June 20, 2013

The BIOTECanada Board of Directors is pleased to announce the election of
David Main, President & CEO, Aquinox Pharmaceuticals, as Chairman of
BIOTECanada at the Annual General Meeting held in Montreal.

“This is an exciting time for the biotechnology industry in Canada, as the
industry brings forward game changing products and technologies in the
healthcare, agricultural and industrial spaces,” commented David Main,
Chairman BIOTECanada. “The industry is an important and growing component of
Canada’s economy. The two hundred and fifty member companies of BIOTECanada
are representative of the regional, size and product diversity of the Canadian
biotech industry. In this context, I am very much looking forward to working
with the Board and my industry colleagues in growing the industry’s economic
and social value in Canada and globally.”

In addition to naming a new Chair, the Board also announced the addition of
new Directors including:

Tony Cruz (CEO, Transition Therapeutics)
Gary Glavin (Associate Vice-President, Research, University of Manitoba)
John Haslam (General Manager, Alexion Pharmaceuticals)
John Norman (Partner, Intellectual Property Group, Gowlings LLP)
Felipe Pastrana (General Manager, AbbVie)

The Board also thanked outgoing Chairman, Brad Thompson for his leadership and
contribution to the industry through the course of his three-year tenure.

“I thank all outgoing Directors for their time and commitment to the
Association. In particular, I thank past-Chair, Brad Thompson, for his
leadership over the course of my first year as President and CEO of
BIOTECanada. Brad’s industry experience and counsel over the past year have
proven indispensable. I am particularly grateful he has agreed to stay on the
Board in his capacity as immediate-past-Chair,” added Andrew Casey, President
and CEO of BIOTECanada.

The new Board is reflective of the intricate eco-system found in the Canadian
biotech sector. The Board members and the organizations they represent are a
microcosm of an industry where large, medium and small corporate entities,
research institutions, academia, and individuals all work together towards
bringing forward biotech solutions to address global health, environmental and
economic challenges.

BIOTECanada is the national industry association that represents Canada’s
biotechnology sector. BIOTECanada membership encompasses companies and
organizations located in thriving clusters nationwide representing the diverse
nature of Canada’s agricultural, health, and industrial biotechnology sectors.
In addition to providing significant health benefits for Canadians, the
biotechnology industry has quickly began re-engineering traditional industries
of the Canadian economy including aerospace, energy, forestry and
manufacturing. In partnership with the Federal Government, BIOTECanada plays a
central role in the development of policy relating to Canada’s growing
bioeconomy.

Contact:

BIOTECanada
Nadine Lunt, 613-230-5585 x257
 
Press spacebar to pause and continue. Press esc to stop.